From Casetext: Smarter Legal Research

Mission Pharmacal Co. v. MainPointe Pharm.

United States District Court, S.D. New York
Nov 16, 2022
22cv4226 (DLC) (S.D.N.Y. Nov. 16, 2022)

Opinion

22cv4226 (DLC)

11-16-2022

Mission Pharmacal Company, Plaintiff, v. MainPointe Pharmaceuticals, LLC, Defendant.


ORDER OF DISCONTINUANCE

DENISE COTE, District Judge:

It having been reported to this Court that this case has been settled, it is hereby

ORDERED that the above-captioned action is discontinued without costs to any party and without prejudice to restoring the action to this Court's calendar if the application to restore the action is made by December 16, 2022, If no such application is made by that date, today's dismissal of the action is with prejudice. See Muze, Inc, v. Digital On Demand, Inc., 356 F.3d 492, 494 n.l (2d Cir. 2004).


Summaries of

Mission Pharmacal Co. v. MainPointe Pharm.

United States District Court, S.D. New York
Nov 16, 2022
22cv4226 (DLC) (S.D.N.Y. Nov. 16, 2022)
Case details for

Mission Pharmacal Co. v. MainPointe Pharm.

Case Details

Full title:Mission Pharmacal Company, Plaintiff, v. MainPointe Pharmaceuticals, LLC…

Court:United States District Court, S.D. New York

Date published: Nov 16, 2022

Citations

22cv4226 (DLC) (S.D.N.Y. Nov. 16, 2022)